Exposure to the non-steroidal anti-inflammatory agent (NSAID) piroxicam uniformly triggers the development of IBD in Il10−/− mice by enhancing apoptosis of mucosal epithelial cells, resulting in barrier breakdown that massively exposes immune cells in the lamina propria to bacterial antigens [5]. The gene discussed is IL10; the disease is inflammatory bowel disease.